Relmada Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND RLMD

Report date

6/30/2026

Quarter

2026 Q2

Filed

7/29/2026

Shares

26,000

Value ($000)

180

Weight

0.0%

2020 Q2 - 2026 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	7/29/2026	180	0.0%	26,000	6/30/2026
2023 Q2	10/8/2025	0	0.0%	192	6/30/2023
2023 Q1	10/8/2025	27	0.0%	12,150	3/31/2023
2022 Q4	10/8/2025	43	0.0%	12,359	12/31/2022
2022 Q3	11/8/2022	1,244	0.0%	33,596	9/30/2022
2022 Q2	8/4/2022	383	0.0%	20,181	6/30/2022
2022 Q1	7/1/2022	352	0.0%	13,044	3/31/2022
2021 Q4	2/2/2022	294	0.0%	13,044	12/31/2021
2021 Q3	11/2/2021	342	0.0%	13,053	9/30/2021
2021 Q2	8/2/2021	417	0.0%	13,014	6/30/2021
2021 Q1	5/11/2021	454	0.0%	12,900	3/31/2021
2020 Q4	2/8/2021	414	0.0%	12,900	12/31/2020
2020 Q3	11/5/2020	485	0.0%	12,900	9/30/2020
2020 Q2	8/7/2020	577	0.0%	12,900	6/30/2020